Chandan Healthcare Ltd vs Molbio Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Chandan Healthcare Ltd is ₹ 218.6 as of 23 Oct 15:30 . The P/E Ratio of Chandan Healthcare Ltd changed from 20 on March 2025 to 19.8 on March 2026 . This represents a CAGR of -0.50% over 2 yearsThe P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Chandan Healthcare Ltd changed from ₹ 442.58 crore on March 2025 to ₹ 536.48 crore on March 2026 . This represents a CAGR of 10.10% over 2 yearsThe Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Chandan Healthcare Ltd for the Jun '26 is ₹ 82.26 crore as compare to the Mar '26 revenue of ₹ 77.43 crore. This represent the growth of 6.24% The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The ebitda of Chandan Healthcare Ltd for the Jun '26 is ₹ 20.98 crore as compare to the Mar '26 ebitda of ₹ 13.32 crore. This represent the growth of 57.51% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The net profit of Chandan Healthcare Ltd changed from ₹ 4.63 crore to ₹ 7.91 crore over 7 quarters. This represents a CAGR of 35.80% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 6 quarters. This represents a CAGR of NaN% The Dividend Payout of Chandan Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Chandan Healthcare Ltd

Chandan Healthcare Limited, established on September 03, 2003, specializes in operating state-of-the-art laboratories that offer comprehensive pathological investigations.
The Company run a diagnostic network in North India with pathology and radiology testing services.
Their services encompass biochemistry, hematology, histopathology, microbiology, and immunology.
Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The Company commenced business by starting its first diagnostic centre in Indra Nagar, Lucknow in 2003.
Later, it started the diagnostic centre in Dehradun in 2013.

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for the comparison of Chandan Healthcare Ltd and null

Which company has a larger market capitalization, Chandan Healthcare Ltd or Molbio Diagnostics Ltd?

Market cap of Chandan Healthcare Ltd is 534 Cr while Market cap of Molbio Diagnostics Ltd is 14,262 Cr

What are the key factors driving the stock performance of Chandan Healthcare Ltd and Molbio Diagnostics Ltd?

The stock performance of Chandan Healthcare Ltd and Molbio Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chandan Healthcare Ltd and Molbio Diagnostics Ltd?

As of October 25, 2026, the Chandan Healthcare Ltd stock price is INR ₹218.6. On the other hand, Molbio Diagnostics Ltd stock price is INR ₹1237.65.

How do dividend payouts of Chandan Healthcare Ltd and Molbio Diagnostics Ltd compare?

To compare the dividend payouts of Chandan Healthcare Ltd and Molbio Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.